• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Ethicon Inc. STRATAFIX Spiral Monocryl Plus; Suture, absorbable, synthetic, polyglycolic acid

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Ethicon Inc. STRATAFIX Spiral Monocryl Plus; Suture, absorbable, synthetic, polyglycolic acid Back to Search Results
Catalog Number SXMP1B119
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Purulent Discharge (1812)
Date of Event 01/01/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a patient underwent a hand surgery on an unknown date and barbed suture was used.The patient encountered pus collection and was treated with i&d.Additional information was requested.
 
Additional Manufacturer Narrative
Product complaint # (b)(4) this is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.D4: udi: the expiration date is currently not available.Therefore, the full udi is currently not available.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested, and the following was obtained: was there any reported patient or user harm? yes did the patient/user require any medical or surgical intervention as a result of the event? yes description for the first incident (on patient's hand), did i&d.For the second incident (on patient's knee), it is to be confirmed as to whether there was surgical intervention.Did the patient/user require extended hospitalization as a result of the event? no what is the patient¿s/user¿s status/outcome following the event? to be confirmed.Nothing being returned for analysis as the product is implanted in patient.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent: did the patient have an infection? please describe the patient manifestations of the reported infection (location, severity, appearance).Please provide the onset date/time of infection from the initial surgical procedure.Were there any pre-existing signs/symptoms of active infection prior to this surgical procedure? did the patient receive any prophylactic antibiotics pre-, intra- or post-operation? were cultures and sensitivities performed? if so, please provide the results.How much and what type of drainage is present in this wound? were any pre-op cleansing procedures changed recently? if yes, please describe what is the surgeon¿s experience with this stratafix suture? please provide the patient's demographic information including age, gender, weight, bmi at the time of index procedure.Date and name of index surgical procedure? the diagnosis and indication for the index surgical procedure? were any concomitant procedures performed? what symptoms did the patient experience following the index surgical procedure? onset date? what was the initial approach for the index surgical procedure? (open, laparoscopic or other)? on what tissue was the suture used? what was the tissue condition (normal, thin, calcified, fragile, diseased)? for the original intended closure, how were all layers closed? please describe any medical/surgical intervention required for this suture event including dates and results.Did the operating surgeon observe any suture deficiency or anomaly before, during, after the suture placement or during any re-operation? was the fixation loop secured to tissue at the initiation of suture use during the index procedure? was at least one reverse stitch performed prior to closure? other relevant patient history/concomitant medications? what is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient's current status?.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATAFIX Spiral Monocryl Plus
Common Device Name
Suture, absorbable, synthetic, polyglycolic acid
Manufacturer (Section D)
Ethicon Inc.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
Ethicon Inc.-San Lorenzo PR
road 183, km 8.3
san lorenzo PR 00754
PR   00754
Manufacturer Contact
orla o'mahony
1000 route 202
raritan, NJ 08869
+1(303)552-6892
MDR Report Key50009367
Report Number2210968-2026-07421
Device Sequence Number8385234
Product Code GAM
UDI-Device Identifier10705031236745
UDI-Public10705031236745
Combination Product (Y/N)Y
Initial Reporter CountryUS
PMA/510(K) Number
K182873
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Type of Report Initial,Followup
Report Date (Section B) 09/04/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberSXMP1B119
Device Lot Number108MBR
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/14/2026
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date07/27/2026
Supplement Report FDA Received Date09/04/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/27/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-